U.S. markets closed

Aethlon Medical, Inc. (AEMD)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.7000+0.1500 (+9.68%)
At close: 3:59PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.31
52-Week Change 3-41.38%
S&P500 52-Week Change 315.56%
52 Week High 34.3400
52 Week Low 30.7600
50-Day Moving Average 31.5208
200-Day Moving Average 31.6104

Share Statistics

Avg Vol (3 month) 3557.13k
Avg Vol (10 day) 3239.46k
Shares Outstanding 512.09M
Float 11.8M
% Held by Insiders 12.66%
% Held by Institutions 110.36%
Shares Short (Nov 12, 2020) 4529.43k
Short Ratio (Nov 12, 2020) 40.46
Short % of Float (Nov 12, 2020) 44.59%
Short % of Shares Outstanding (Nov 12, 2020) 44.38%
Shares Short (prior month Oct 14, 2020) 41.15M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Oct 14, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 30, 2020
Most Recent Quarter (mrq)Sep 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)-942.20%

Management Effectiveness

Return on Assets (ttm)-44.71%
Return on Equity (ttm)-85.21%

Income Statement

Revenue (ttm)620.19k
Revenue Per Share (ttm)0.08
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)650.19k
Net Income Avi to Common (ttm)-5.78M
Diluted EPS (ttm)-0.7060
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.47M
Total Cash Per Share (mrq)1.2
Total Debt (mrq)92.6k
Total Debt/Equity (mrq)0.68
Current Ratio (mrq)9.90
Book Value Per Share (mrq)1.13

Cash Flow Statement

Operating Cash Flow (ttm)-5.21M
Levered Free Cash Flow (ttm)-3.07M